DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02410 TYK MEDICINES-B

Trading Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind, Stock Connect HK MS, Stock Connect HK S I
Major Shareholders WU Yusheng & Associates (35.39%)
Jiangsu Addor Equity Investment Fund Management Co.,Ltd. (5.50%)
HE Chao & Associates (5.23%)		 Sector Health Care & Biotechnology
Web Site http://www.tykmedicines.com Tel (86 21) 6167-6766
Email investors@tykmedicines.com Fax (86 21) 6010-7317
Related Equities N/A
Principal Activities Principally engaged in the research, development and commercialisation of pharmaceutical products.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top